In non-small cell lung cancer (NSCLC), PCK1 can promote nuclear SREBP-1 activation by phosphorylating Insig1/2, which is associated with TNM stage and progression of NSCLC (104). This evidence concerns the gene INSIG1 and non-small cell lung carcinoma.